213 related articles for article (PubMed ID: 17302188)
41. The role of human papillomavirus vaccines in cervical cancer: Prevention and treatment.
Bogani G; Leone Roberti Maggiore U; Signorelli M; Martinelli F; Ditto A; Sabatucci I; Mosca L; Lorusso D; Raspagliesi F
Crit Rev Oncol Hematol; 2018 Feb; 122():92-97. PubMed ID: 29458794
[TBL] [Abstract][Full Text] [Related]
42. Modern screening in cervical cancer. Perspectives of HPV prophylactic vaccines.
Vlădăreanu R; Andrei C
Rev Med Chir Soc Med Nat Iasi; 2007; 111(1):144-54. PubMed ID: 17595860
[TBL] [Abstract][Full Text] [Related]
43. Human papillomavirus quadrivalent vaccine: a look behind the numbers.
Flaherty DK; Alkhateeb FM
Ann Pharmacother; 2009 Apr; 43(4):740-4. PubMed ID: 19276314
[TBL] [Abstract][Full Text] [Related]
44. Recent advances in human papillomavirus vaccines.
Mahdavi A; Monk BJ
Curr Oncol Rep; 2006 Nov; 8(6):465-72. PubMed ID: 17091565
[TBL] [Abstract][Full Text] [Related]
45. [Prevention of cervical cancer by HPV vaccine].
Konno R
Gan To Kagaku Ryoho; 2010 Feb; 37(2):236-9. PubMed ID: 20235395
[No Abstract] [Full Text] [Related]
46. Human papillomavirus disease and vaccines.
Hutchinson DJ; Klein KC
Am J Health Syst Pharm; 2008 Nov; 65(22):2105-12. PubMed ID: 18997137
[TBL] [Abstract][Full Text] [Related]
47. Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine: up to 8.4 years of follow-up.
Roteli-Martins CM; Naud P; De Borba P; Teixeira JC; De Carvalho NS; Zahaf T; Sanchez N; Geeraerts B; Descamps D
Hum Vaccin Immunother; 2012 Mar; 8(3):390-7. PubMed ID: 22327492
[TBL] [Abstract][Full Text] [Related]
48. Variation in genital human papillomavirus infection prevalence and vaccination coverage among men and women in the USA.
Han JJ; Tarney CM; Song J
Future Oncol; 2017 Jun; 13(13):1129-1132. PubMed ID: 28589730
[TBL] [Abstract][Full Text] [Related]
49. [Human papillomavirus vaccines: a new challenge for pediatricians].
Martinón-Torres F; Bernaola Iturbe E; Giménez Sánchez F; Baca Cots M; De Juan Martín F; Díez Domingo J; Garcés Sánchez M; Gómez Campderá JA; Picazo JJ; Pineda Solas V
An Pediatr (Barc); 2006 Nov; 65(5):461-9. PubMed ID: 17184607
[TBL] [Abstract][Full Text] [Related]
50. Cervical Cancer, Human Papillomavirus Infection, and Vaccine-Related Knowledge: Awareness in Chinese Women.
Yuanyue L; Baloch Z; Shanshan L; Yasmeen N; Xiaomei W; Khan JM; Xueshan X
Cancer Control; 2018; 25(1):1073274818799306. PubMed ID: 30213198
[TBL] [Abstract][Full Text] [Related]
51. Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model.
Gomez JA; Lepetic A; Demarteau N
BMC Public Health; 2014 Nov; 14():1222. PubMed ID: 25424716
[TBL] [Abstract][Full Text] [Related]
52. Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing.
Wheeler CM
Nat Clin Pract Oncol; 2007 Apr; 4(4):224-35. PubMed ID: 17392713
[TBL] [Abstract][Full Text] [Related]
53. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
Guo T; Eisele DW; Fakhry C
Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637
[TBL] [Abstract][Full Text] [Related]
54. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
Hantz S; Alain S; Denis F
Gynecol Obstet Fertil; 2006; 34(7-8):647-55. PubMed ID: 16807045
[TBL] [Abstract][Full Text] [Related]
55. Chapter 17: Second generation HPV vaccines to prevent cervical cancer.
Schiller JT; Nardelli-Haefliger D
Vaccine; 2006 Aug; 24 Suppl 3():S3/147-53. PubMed ID: 16950002
[TBL] [Abstract][Full Text] [Related]
56. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
Harper DM
Public Health Genomics; 2009; 12(5-6):319-30. PubMed ID: 19684444
[TBL] [Abstract][Full Text] [Related]
57. [Vaccines for precancer and cancer of the uterine cervix. II. Therapeutic HPV vaccines].
Kostova P; Zlatkov V
Akush Ginekol (Sofiia); 2007; 46(8):31-5. PubMed ID: 18642554
[TBL] [Abstract][Full Text] [Related]
58. Human papillomavirus-related content in state and tribal comprehensive cancer control plans.
Steele CB; Thomas CN; Richardson LC
J Womens Health (Larchmt); 2008; 17(1):5-10. PubMed ID: 18240976
[TBL] [Abstract][Full Text] [Related]
59. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
Bégué P; Henrion R; Blanc B; Girard M; Sancho-Garnier H
Bull Acad Natl Med; 2007 Dec; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
[TBL] [Abstract][Full Text] [Related]
60. [Cervical cancer prevention: the impact of HPV vaccination].
Monsonégo J
Gynecol Obstet Fertil; 2006 Mar; 34(3):189-201. PubMed ID: 16529969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
